Solu-Cortef

Product name and form

Solu-Cortef 100 mg or Hydrocortisone sodium succinate for injection BP 100 mg.

Pharmaceutical Form

White, freeze dried powder for parenteral use.

Qualitative and quantitative composition

Each vial contains Hydrocortisone sodium succinate 133.7 mg equivalent to hydrocortisone 100.0 mg.

List of Excipients

Sodium biphosphate
Sodium phosphate

Pack sizes and marketing

Type I flint glass vials with a butyl rubber plug and metal seal. Each vial of Solu-Cortef 100 mg contains the equivalent of 100 mg hydrocortisone as the sodium succinate for reconstitution with 2 ml of Sterile Water for Injections.

Marketing authorization holder

Pharmacia Limited
Ramsgate Road
Sandwich
Kent
CT13 9NJ
UK

Marketing authorization dates and numbers

PL 0032/5019

Date of first authorisation (PL 0032/5019): 18 May 1990

Last renewal date: 15 March 2005

Drugs

Drug
Countries
Australia, Canada, Finland, Hong Kong, Ireland, Netherlands, Singapore, United Kingdom, United States